"Cholesterol, VLDL" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cholesterol which is contained in or bound to very low density lipoproteins (VLDL). High circulating levels of VLDL cholesterol are found in HYPERLIPOPROTEINEMIA TYPE IIB. The cholesterol on the VLDL is eventually delivered by LOW-DENSITY LIPOPROTEINS to the tissues after the catabolism of VLDL to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LDL.
| Descriptor ID |
D015243
|
| MeSH Number(s) |
D04.210.500.247.808.197.247 D10.532.599.700 D10.570.938.208.285 D12.776.521.622.700
|
| Concept/Terms |
Cholesterol, VLDL- Cholesterol, VLDL
- VLDL Cholesterol
- Pre-beta-Lipoprotein Cholesterol
- Cholesterol, Pre-beta-Lipoprotein
- Pre beta Lipoprotein Cholesterol
- Very Low Density Lipoprotein Cholesterol
- Prebetalipoprotein Cholesterol
- Cholesterol, Prebetalipoprotein
|
Below are MeSH descriptors whose meaning is more general than "Cholesterol, VLDL".
Below are MeSH descriptors whose meaning is more specific than "Cholesterol, VLDL".
This graph shows the total number of publications written about "Cholesterol, VLDL" by people in this website by year, and whether "Cholesterol, VLDL" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 2 | 2 |
| 2003 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cholesterol, VLDL" by people in Profiles.
-
Li C, Ford ES, McBride PE, Kwiterovich PO, McCrindle BW, Gidding SS. Non-high-density lipoprotein cholesterol concentration is associated with the metabolic syndrome among US youth aged 12-19 years. J Pediatr. 2011 Feb; 158(2):201-7.
-
Wiviott SD, Mohanavelu S, Raichlen JS, Cain VA, Nissen SE, Libby P. Safety and efficacy of achieving very low low-density lipoprotein cholesterol levels with rosuvastatin 40 mg daily (from the ASTEROID Study). Am J Cardiol. 2009 Jul 01; 104(1):29-35.
-
Millar JS, Duffy D, Gadi R, Bloedon LT, Dunbar RL, Wolfe ML, Movva R, Shah A, Fuki IV, McCoy M, Harris CJ, Wang MD, Howey DC, Rader DJ. Potent and selective PPAR-alpha agonist LY518674 upregulates both ApoA-I production and catabolism in human subjects with the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2009 Jan; 29(1):140-6.
-
Morgan JM, Capuzzi DM, Baksh RI, Intenzo C, Carey CM, Reese D, Walker K. Effects of extended-release niacin on lipoprotein subclass distribution. Am J Cardiol. 2003 Jun 15; 91(12):1432-6.
-
Tulenko TN, Sumner AE. The physiology of lipoproteins. J Nucl Cardiol. 2002 Nov-Dec; 9(6):638-49.
-
Karalis DG, Ross AM, Vacari RM, Zarren H, Scott R. Comparison of efficacy and safety of atorvastatin and simvastatin in patients with dyslipidemia with and without coronary heart disease. Am J Cardiol. 2002 Mar 15; 89(6):667-71.
-
Iozzo RV, Kushwaha RS, Wight TN, Hazzard WR. Cellular and subcellular distribution of 125I-labeled very low density lipoproteins in the liver of normal and estrogen-treated rabbits. Am J Pathol. 1982 Apr; 107(1):6-15.